Principal Investigator
Abdulrahman Sinno
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230999
Clinical Trial Summary
A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cisplatin versus no HIPEC at the Time of Interval Cytoreductive Surgery followed by Niraparib Maintenance in Patients with Newly Diagnosed Stage III and IV Ovarian, Primary
Peritoneal, and Fallopian Tube Cancer (Hyperthermic Ovarian Treatment Trial)
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Gynecologic Cancer
Contact Information
Phone Number
305-243-2647